Exosome Diagnostics Raises $20 Million
Exosome Diagnostics Inc., a New York-based developer of minimally-invasive molecular diagnostics, has raised $20 million in Series A funding. NGN Capital and Forbion Capital Partners co-led the round.
12 May 2010•4 mins read
